XML 32 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1

Accrued Expenses and Other Current Liabilities

6 Months Ended

12 Months Ended

Jun. 30, 2017

Dec. 31, 2016

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

3. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

		June 30, 2017				December 31, 2016
Clinical trial costs		$	899			$	3,088
Professional fees			660				229
Compensation and related benefits			976				975
Interest expense			99				—
Accrued expenses and other current liabilities		$	2,634			$	4,292

4. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

		December 31,
		2016				2015
Clinical development expense		$	3,088			$	3,294
Professional fees			229				435
Compensation and related benefits			975				1,535
Interest expense			—				28
Accrued expenses and other current liabilities		$	4,292			$	5,292

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration